Novo Nordisk A/S
Novo Nordisk is seeking a Translational Specialist to support clinical development by linking drug and disease mechanisms to biomarker strategies and clinical decision‑making. The role leads cross‑functional translational teams, identifies and qualifies biomarkers, and drives biomarker plans to de‑risk the portfolio while bridging preclinical insights with human disease biology.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Senior Scientist
Merck & Co., Inc.
Director, Oncology Early Translational Biomarkers
GSK plc
Associate Director, Translational Science (Neurology)
Eisai
Director, Translational Science (Neurology)
Eisai
Vice President, Translational Medicine
Annexon Biosciences
Director Translational Science Lead Respiratory
GSK plc